Subscribe

One email a week: new science briefs plus cross-border licensing, M&A and clinical-data briefs, each with a source link. Free; unsubscribe any time.

Sign up

Opens your email app with a pre-filled request; we add you by hand. Free, unsubscribe any time.

Or email contact@inlightbio.com with the subject “Subscribe [EN]” and we will add you to the weekly list.

Prefer a feed? Use RSS, or follow InLight Bio on LinkedIn.

What you get

  • New science briefs: recent papers and preprints, with study design, key numbers and a DOI link.
  • New cross-border licensing and M&A deals, with upfront and milestones separated.
  • Clinical readouts that change the value of China-originated assets.
  • Upcoming partnering and investor meetings.

Deal or partnership inquiries go to bd@inlightbio.com, not the newsletter address.